# Taste Assessment Study of 2 Atazanavir Powder Formulations in Healthy Subjects

> **NCT01404572** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 12 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Atazanavir (current formulation)
- **DRUG:** Atazanavir, powder for oral use 1 (POU1)
- **DRUG:** Atazanavir (POU2)

## Key facts

- **NCT ID:** NCT01404572
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01404572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01404572, "Taste Assessment Study of 2 Atazanavir Powder Formulations in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01404572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*